Re: Shandong serious illness insurance coverage expansion next month, a variety of anti-cancer drugs into medical insurance
14 kinds of drugs, which are expected to be less than half of the money
bingo (universal name: ragani), are expected to be included in the coverage of the big disease insurance, and many of them are the most recent target drugs (anticancer drugs) that have been the most popular because of the film "I am not the drug God". What is the actual burden reduction for patients after being included in the medical insurance? What is the situation of the current use of targeted drugs?
among the 14 drugs included in the coverage of medical insurance, including the antitumor targeting drugs, such as Bai Wan Ge, Teresa (general name: ootici mesylate), and CESCO (general name: Crizotinib Capsules). In recent hot film "I am not a drug God" drug, Gleevec is also an anti-cancer targeting drug. In fact, because of the aristocratic drugs and most of the reasons for not entering medical insurance, many anticancer targeting drugs are similar to the gleevy in the film. Niu Zuoxing, the director of the four disease area in Shandong Tumor Hospital, is different from tumor chemotherapeutic drugs. Targeted drugs can make the drug form relatively high concentration in the target area, thus reducing the side effects and reducing the damage to normal tissues and cells. It is a new favorite for cancer treatment in recent years.
it is known that more than 100 kinds of tumor targeting drugs have been found worldwide, but only 25.4% of these tumor targeting drugs are listed in China, which makes the majority of tumor targeting drugs unable to buy in China. At present, the patent protection period of many foreign targeted drugs has passed, and many domestic cancer targeting drugs have been listed. For example, the price of imported Gleevec is priced at 10500 yuan a box. The price of domestic Gleevec produced by two pharmaceutical factories in Jiangsu is about 3000 yuan per box. But compared to India generic drugs, these domestic generics still have no price advantage.
Niu Xing Xing said that because of the high price and most of them could not afford medical insurance, the patients treated with targeted drugs were less than 1/10. However, many anticancer drugs including Gleevec have been included in the reimbursement range in recent years. A variety of anti-cancer drugs have been included in the serious illness insurance, which has brought the gospel to cancer patients.
he made an account to reporters: if we use this time to incorporate into the serious illness medical insurance, we will be a tumor targeting drug for the treatment of colorectal cancer and liver cancer. After entering a certain course, the patient needs to take this medicine. It usually takes 3 weeks and rest for 1 weeks. It will take an average of 3 months, and the drug resistance will no longer be eaten. The drug imports a box of 10 thousand yuan, a month to bear more than 30 thousand yuan, 3 months to eat to spend nearly 100 thousand yuan. General patients can not afford to spend, so many people give up treatment. After the introduction of medical insurance, the drug can reimburse 40%-60%, which will greatly reduce the burden of patients.
but some experts admit that because the price of these drugs is higher, even if the medical insurance can reimburse part of the drugs, the rest is still a heavy burden for the patients. And the tumor targeting drug that did not enter the medical insurance directory will not enter the hospital, and it will only be sold in the designated pharmacy. Another point to note is that not only expensive, but also many target drugs. Targeted drugs in the medical insurance directory, the hospital can be imported, but involved in the problem of drug ratio, doctors will take such drugs to exceed the standard, leading to hospital and doctors do not dare to open.
for the phenomenon of targeting drug targeting drugs from abroad, it is said that the imitation drugs still have a certain technical threshold, such as the target drug that is a target drug for lymphoma, which is very complex, a little difference in the four level structure, and a false effect, so even after the patent expires, it is still at home and abroad. But no manufacturer can copy it. At the same time, fake drugs bought from unknown channels can not be guaranteed.